- $132.09m
- $446.10m
- $114.20m
Annual income statement for Agenus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 296 | 98 | 156 | 103 | 114 |
| Cost of Revenue | |||||
| Gross Profit | 292 | 87.5 | 153 | 103 | 113 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 264 | 279 | 316 | 224 | 33.6 |
| Operating Profit | 31.9 | -181 | -160 | -120 | 80.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -28.7 | -231 | -257 | -232 | -3.08 |
| Net Income After Taxes | -28.7 | -231 | -257 | -232 | -3.08 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -23.9 | -220 | -246 | -227 | 0.115 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -24.1 | -220 | -246 | -227 | -0.101 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.65 | -15.5 | -13.7 | -10.8 | -3.39 |